Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  fluorine F 18 fluorothymidine
Find trials that include:  Any drugs shown
Trial Status:  Active
Results 1-25 of 40 for your search:
Start Over
18F-FLT Positron Emission Tomography and Magnetic Resonance Imaging of the Breast
Phase: Phase IV
Type: Diagnostic
Status: Active
Age: 20 to 80
Sponsor: Other
Protocol IDs: 201102011MB, NCT01956890
A Study to Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma
Phase: Phase II, Phase I
Type: Diagnostic
Status: Active
Age: 16 and over
Sponsor: Other
Protocol IDs: SP-24513/DX-FLT-002, NCT01065805
Molecular Imaging With Erlotinib and Bevacizumab
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: MIMEB, 2009-012607-26, NCT01047059
Pilot Study of Lupron to Improve Immune Function After Allogeneic Bone Marrow Transplantation
Phase: Phase II
Type: Treatment
Status: Active
Age: 9 to 40
Sponsor: NCI
Protocol IDs: 110136, 11-C-0136, NCT01338987
A Study to Assess the Ability of a Novel Endocrine Treatment for Breast Cancer, Irosustat, to Slow Down Cancer Growth
Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: C/24/2011, 2011-005240-10, X-52-58064-011, NCT01662726
[F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 201204712, R01CA169336, NCT01717391
FLT PET/CT in Measuring Response in Patients With Previously Untreated Acute Myeloid Leukemia
Phase: Phase II
Type: Diagnostic, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2015-00328, EAI141, U10CA180820, U10CA180827, NCT02392429
Vemurafenib Plus Cobimetinib in Metastatic Melanoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: M14REP, NCT02414750
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Phase: Phase I
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000647210, P30CA022453, WSU-2006-127, PFIZER-WSU-2006-127, 2006-127, NCT00935090
Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCC
Phase: Phase I
Type: Treatment
Status: Active
Age: 19 and over
Sponsor: NCI, Other
Protocol IDs: MCC 13222, NCI-2010-02340, P30CA016059, NCT01283178
Monitor Response to Treatment in Neuroblastoma Using 3&Apos;-Deoxy-3&Apos;-Fluorothymidine- Positron Emission Tomography (FLT-PET)
Phase: Phase I
Type: Diagnostic
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: WSU 2009-031, NCT01308905
VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Docetaxel in Treating Patients With Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: UW13112, NCI-2014-00944, P30CA014520, NCT02146222
An Imaging Pilot Study of 18F-fluoro-3'-Deoxy-3'-L-fluorothymidine (18F-FLT) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Who Will be Treated With Gemcitabine
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: SP-14-0054 / 23061, NCT00414570
Correlation Between Fluorodeoxyglucose (FDG) and FLT Uptake and Gene-Expression Oncotype Assay in Patients With Breast Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Approved-not yet active
Age: 18 to 86
Sponsor: Other
Protocol IDs: TASMC-08-EE-108-CTIL, NCT00688337
Multi-Tracer PET Assessment of Primary Brain Tumors
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: HCI31335, NCT00813566
The Role of Positron Emission Tomography (PET) During Erlotinib Treatment for Non-small Cell Lung Cancer
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 to 85
Sponsor: Other
Protocol IDs: AMC-2008-0511, NCT01000428
Early Prediction of Pathologic Complete Response (pathCR) With Fluoro-L-Thymidine (FLT) Positron Emission Tomography (PET)
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: AAAD5444, R21CA121551, NCT01065818
Clinical Application of 18F-3'-Fluoro-3'-Deoxy-L-thymidine (18F-FLT) Positron Emission Tomography (PET) in Lung Tumors
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Active
Age: 18 to 90
Sponsor: Other
Protocol IDs: 200712071R, NCT01089894
Positron Emission Tomography (PET)-Computed Tomography (CT) PET/CT Evaluation of Treatment Response in Breast Cancer
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: VICC BRE 09108, NCT01222416
Personalized Translational Platform for Biomarker Discovery in Brain Tumors
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 to 85
Sponsor: Other
Protocol IDs: 2008P000554, NCT01240161
FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large B-cell Lymphoma
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: LYMIMG0001, SU-07072011-8046, 19997, NCT01410630
FLT-PET Imaging for MDS
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: HO10417, NCT01535456
F18-FLT PET/CT as a Tool for Assessment of Myeloablative Treatment in Patients With Acute Myeloid Leucemia(AML)
Phase: No phase specified
Type: Diagnostic
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: 0112-12-HMO, NCT01592266
Study of the Predictive Marker FLT in Patients Suffering From AML
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CIMS-2011-01, NCT01599429
Pilot Study for Evaluating the Role of F-18 FLT PET/CT in Therapeutic Decision Making in Non-small Cell Lung Cancer
Phase: No phase specified
Type: Diagnostic
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: KC12EISI0104, NCT01619241
Start Over